Search Results - "M. E. Abramov"

Treatment tactics of non-small-cell lung cancer with erlotinib: literature review and description of a clinical case by Borisova, E. I., Gutorov, S. L., Abramov, M. E.

“…Erlotinib is a small-molecule inhibitor of EGFR tyrosine kinase domain, which has shown effectiveness in the treatment of non-small cell lung cancer with…”
Get full text

Ixabepilone: new perspectives for its use in breast cancer by A. A. Mescheryakov, E. V. Lubennikova, M. E. Abramov

“…Despite significant advances in recent years, the drug therapy for breast cancer (BC) is still based on chemotherapy. The introduction of new effective…”
Get full text

TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER by O. O. GORDEEVA, M. E. ABRAMOV, A. N. LUD

“…Gastric cancer is one of the leading causes of death among all cancers in Russia. Progression-free and overall survival cannot be drastically changed by…”
Get full text

Nab-paclitaxel in the treatment of breast cancer: clinical trial data and first-hand experience by E. I. Borisova, S. P. Gutorov, G. V. Vyshinskaya, N. V. Dobrova, M. E. Abramov

“…The article considers the place of nab-paclitaxel in the treatment of metastatic breast cancer. A number of studies have shown high efficacy and acceptable…”
Get full text

The role of erythropoietins in cancer therapy by O. E. Kondratieva, M. E. Abramov, G. V. Vyshinskaya, S. L. Gutorov, E. I. Borisova, E. V. Cherniglazova

“…Anemia is a common hematological complication in cancer patients receiving chemotherapy. Reduction of hemoglobin level is accompanied by a significant…”
Get full text

POS-628 THE IMPACT OF OBESITY ON ADVERSE OUTCOME OF COVID-19 IN PATIENTS ON MAINTENANCE HEMODIALYSIS DUE TO DIABETIC KIDNEY DISEASE by Zeltyn-Abramov M., E., Belavina I., N., Frolova F., N., Poteshkina G., N., Klochkova N., N., Kondrashkina V., S., Sokolova V., N.

Get full text

Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease by Zeltyn-Abramov, E. M., Lysenko, M. A., Frolova, N. F., Markova, T. N., Belavina, N. I., Klochkova, N. N., Kondrashkina, S. V., Iskhakov, R. T., Ushakova, A. I.

“…BACKGROUND : Patients with Type 2 Diabetes (T2DM) and patients on maintenance hemodialysis (MHD) are at a high risk of adverse clinical course of COVID-19. To…”
Get full text

INFLUENCE OF THE RECOMBINANT TUMOR NECROSIS FACTOR THYMOSIN-α1 ON ANGIOGENESIS IN DISSEMINATED SKIN MELANOMA PATIENTS by I. A. KOROLEVA, E. G. SLAVINA, A. I. CHERTKOVA, V. A. NURTDINOVA, E. K. SHOUA, M. E. ABRAMOV, Z. G. KADAGIDZE

“…The article covers the results of clinical application of a domestic drug based on recombinant tumor necrosis factor-alphathymosin-alpha1 (Refnot) in 20…”
Get full text

Reversible pulmonary hypertension in post -renaltransp lantation patient with longst anding arteriovenous fistula by E. M. Zeltyn-Abramov, R. T. Iskhakov, L. Yu. Artyukhina, E. S. Ivanova, O. V. Manchenko, N. I. Belavina, N. A. Tomilina

“…Case report of reversible high pulmonary hypertension (PH) in patient with successful kidney transplantation (KT) is presented. The distinction of the case was…”
Get full text

EXTERNAL MYOCARDIAL RUPTURE IN ACUTE PHASE OF MYOCARDIAL INFARCTION: CLINICAL AND INSTRUMENTAL PREDICTORS by E. M. Zeltyn’-Abramov, A. E. Radzevich

“…The retrospective univariable and multivariable analyses of 263 medical histories of patients with acute myocardial infarction, AMI (61 cases of external…”
Get full text

Determination of variations of the primary structure of the UGT1A1, DPYD, GSTP1, and ABCB1 genes involved in the metabolism of antitumor agents by Titov, S. V., Heydarov, R. N., Abramov, M. E., Timofeev, E. N., Mikhailovich, V. M.

“…A individual approach to the treatment of cancer patients, which takes the genetic features of the patient’s metabolism into account, allows one to choose an…”
Get full text

BRCA-associated ovarian cancer: a review of the current literature by Tikhomirova, T. E., Tyulyandina, A. S., Rumyantsev, A. A., Abramov, M. E., Anokhin, A. Yu, Lud, A. N., Tjulandin, S. A.

“…Ovarian cancer is a heterogeneous disease and is the leading cause of mortality among all gynecological malignancies. The disease is characterized by a high…”
Get full text

Cellular markers based on DNA damage and repair (BER, MMR), expression of MLHI, MSH2, FasR, and cell death of lymphocytes as predictive parameters for clinical response to chemotherapy of melanoma by Tronov, V A, Artamonov, D N, Abramov, M E, Gorbacheva, L B

“…Melanoma is a highly aggressive neoplastic disease attributed to transformed melanocytes. The efficacy of regimens of cytotoxic chemotherapy for advanced stage…”
Get more information

Cellular markers based on DNA repair (BER, MMR) expression of MLH1, MSH2, FasR and death of lymphocytes as predictive parameters for clinical response to chemotherapy of melanoma patients by Tronov, V. A., Artamonov, D. N., Abramov, M. E., Gorbacheva, L. B.

“…Melanoma is a highly aggressive tumor of melanocytes. The efficacy of different cytotoxic chemotherapy regimens does not exceed 20%. The search for markers for…”
Get full text

Effectiveness of DNA repair and expression of MLH1, MSH2 and FASR in lymphocytes of patients with chemotherapy-responsive, disseminated cutaneous melanoma by Tronov, V A, Artamonov, D N, Abramov, M E, Gorbacheva, L B, Lichinitser, M R

“…Patients with advanced malignant melanoma have poor prognosis as conventional chemotherapy induces complete response in a very small fraction (not more than…”
Get more information

Sovremennye aspektyprofilaktiki neytropeniipri khimioterapii solidnykh opukholey by M E Abramov, L G Zhukova

Get full text

Thrombolytic therapy and cardiac free wall rupture in patients with acute myocardial infarction by E M Zeltyn-Abramov, A E Radzevitch

“…The possible connection between thrombolytic therapy (TT) and the risk of left ventricle free wall rupture (LVFWR) in patients with acute myocardial infarction…”
Get full text

Metrological examination of technological documents by Abramov, E. M., Vel'tishchev, Yu. I.

Get full text

Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom by L G Zhukova, M E Abramov, Yu V Vakhabova, A N Lud, A A Obukhov, M R Lichinitser

“…Внедрение в клиническую практику большого количества эффективных схем цитостатической терапии позволило, с одной стороны, сделать излечимыми ряд…”
Get full text

Clinical and instrumental predictors of upcoming cardiac free wall rupture due to acute miocardial infarction by E M Zeltyn-Abramov, A E Radzevitch, N I Belavina, V N Nesvetov, N N Klochcova

“…Medical records and autopsy reports of 839 patients admitted to City Hospital N52 were reviewed. 42 patients died from cardiac free wall rupture…”
Get full text